Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, N-1346, Gjettum, Norway.
Department of Medicine, Diakonhjemmet Hospital, Oslo, Norway.
BMC Geriatr. 2021 Mar 22;21(1):199. doi: 10.1186/s12877-021-02140-x.
Older people are particularly vulnerable to severe COVID-19. Little is known about long-term consequences of COVID-19 on health-related quality of life (HR-QoL) and functional status in older people, and the impact of age in this context. We aimed to study age-related change in health-related quality of life, functional decline and mortality among older patients 6 months following hospitalisation due to COVID-19.
This was a cohort study including patients aged 60 years and older admitted to four general hospitals in South-Eastern Norway due to COVID-19, from March 1 up until July 1, 2020. Patients who were still alive were invited to attend a six-month follow-up. Change in HR-QoL and functional status compared to before the COVID-19 hospitalisation were assessed using the EuroQol 5-dimensional-5 levels questionnaire (EQ. 5D-5L). A change in visual analogue scale (VAS) score of 7 or more was considered clinically relevant.
Out of 216 patients aged 60 years and older that were admitted to hospital due to COVID-19 during the study period, 171 were still alive 180 days after hospital admission, and 106 patients (62%) attended the six-month follow-up. Mean age was 74.3 years, 27 patients (26%) had experienced severe COVID-19. Fifty-seven participants (54%) reported a decrease in the EQ. 5D-5L VAS score after 6 months, with no significant difference between persons aged 75 years and older compared to younger. Seventy participants (66%) reported a negative change in any of the dimensions of the EQ. 5D-5L, with impaired ability to perform activities of daily life (35%), reduced mobility (33%) and having more pain or discomfort (33%) being the most commonly reported changes. Forty-six participants (43%) reported a negative change in cognitive function compared to before the COVID-19 hospitalisation. Six-month mortality was 21%, and increased with increasing age.
More than half of the patients reported a negative change in HR-QoL 6 months following hospitalisation due to COVID-19, and one out of three experienced a persistently impaired mobility and ability to carry out activities of daily living. The results suggest awareness of long-term functional decline in older COVID-19 patients.
老年人尤其容易受到严重 COVID-19 的影响。对于 COVID-19 对老年人健康相关生活质量(HR-QoL)和功能状态的长期影响,以及年龄在这方面的影响,知之甚少。我们旨在研究 COVID-19 住院后 6 个月老年人健康相关生活质量、功能下降和死亡率的年龄相关性变化。
这是一项队列研究,纳入了 2020 年 3 月 1 日至 7 月 1 日期间因 COVID-19 入住挪威东南部四家综合医院的年龄在 60 岁及以上的患者。仍存活的患者受邀参加 6 个月的随访。使用 EuroQol 5 维 5 级问卷(EQ.5D-5L)评估与 COVID-19 住院前相比,HR-QoL 和功能状态的变化。视觉模拟量表(VAS)评分变化 7 分或以上被认为具有临床意义。
在研究期间,因 COVID-19 住院的 216 名 60 岁及以上的患者中,171 名在住院后 180 天仍存活,106 名(62%)参加了 6 个月的随访。平均年龄为 74.3 岁,27 名(26%)患者患有严重 COVID-19。57 名参与者(54%)在 6 个月后报告 EQ.5D-5L VAS 评分下降,75 岁及以上人群与年轻人群相比无显著差异。70 名参与者(66%)报告 EQ.5D-5L 的任何维度都出现了负面变化,其中日常生活活动能力受损(35%)、移动能力下降(33%)和更多疼痛或不适(33%)是最常见的变化。46 名参与者(43%)报告与 COVID-19 住院前相比,认知功能出现负面变化。6 个月死亡率为 21%,且随年龄增长而增加。
COVID-19 住院后 6 个月,超过一半的患者报告 HR-QoL 出现负面变化,三分之一的患者持续出现移动能力受损和日常生活活动能力下降。结果提示应关注老年 COVID-19 患者的长期功能衰退。